Regulus Therapeutics Inc. — Form D

Regulus Therapeutics Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-23. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
John E MaraganoreDirectorSan Diego, CA
Garry Lynne MenzelExecutive OfficerSan Diego, CA
Joseph HaganDirectorNASHVILLE, TN
Joseph HaganExecutive OfficerNASHVILLE, TN
William H RastetterDirectorSan Diego, CA
Stelios PapadopoulosDirectorBrooklyn, NY
Barry E GreeneDirectorNewton, MA
Christopher AkerExecutive OfficerSan Diego, CA
Alice S HuangDirectorSan Diego, CA
Cris CalsadaExecutive OfficerSan Diego, CA
Jake R NunnDirectorSan Diego, CA
David BaltimoreDirectorSan Diego, CA
Denis DryginExecutive OfficerSan Diego, CA
Pascale H WitzDirectorSan Diego, CA
Simos H SimeonidisDirectorSan Diego, CA
Hugh H RosenDirectorSan Diego, CA
Mark G FolettaDirectorSan Diego, CA
Joseph P HaganDirectorSan Diego, CA
Joseph P HaganExecutive OfficerSan Diego, CA
Daniel R ChevallardExecutive OfficerSan Diego, CA
Christopher R AkerExecutive OfficerSan Diego, CA
David R BaltimoreDirectorSan Diego, CA
Stelios R PapadopoulosDirectorSan Diego, CA
Kathryn L CollierDirectorSan Diego, CA
Kleanthis XanthopoulosDirectorCarlsbad, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2021-12-06D$34.6M$34.6M
2020-12-17D$34.5M$19.4M
2019-05-14D$79.3M$16.7M
2014-02-06D$10.0M$10.0M
2012-10-23D$5.0M$5.0M
2010-11-15D$20.0M$20.0M
2010-11-15D$10.0M$10.0M
2010-11-15D$29.8M$29.8M

More